Evaluation of Namibia's antiretroviral therapy guidelines' recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study.
Francis KalemeeraS T NdevahomaM MubitaBrian GodmanPublished in: Expert review of anti-infective therapy (2021)
A VL >1000 copies/ml was a predictor of switching. New local research is underway, with a large number of patients, to assess whether this finding applies to the dolutegravir-based regimens.